Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heart Transplant Recipients”

153 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 153 results

Post-approval studies (Phase 4)Study completedNCT00189150
What this trial is testing

Pharmacokinetics of Mmf and Valganciclovir

Who this might be right for
Kidney Transplant RecipientHeart Transplant Recipient
University of Michigan 16
Not applicableStudy completedNCT01760538
What this trial is testing

Study on Heart Rate Variability in Cardiac Transplant Recipients With Exercise and After Exercise Training

Who this might be right for
Cardiac Transplant Disorder
National Taiwan University Hospital 30
Not applicableStudy completedNCT02178943
What this trial is testing

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

Who this might be right for
Cardiac Transplant FailureCardiac Transplant RejectionHeart Diseases
CareDx 100
Large-scale testing (Phase 3)WithdrawnNCT01157949
What this trial is testing

Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)

Who this might be right for
Cardiac Allograft Vasculopathy
Cedars-Sinai Medical Center
Large-scale testing (Phase 3)Study completedNCT03734211
What this trial is testing

Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients

Who this might be right for
Cardiac Allograft Vasculopathy
Lars Gullestad 130
Post-approval studies (Phase 4)Study completedNCT00812786
What this trial is testing

Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant Patients

Who this might be right for
Heart Transplant
University Hospital, Limoges 42
Post-approval studies (Phase 4)UnknownNCT00421005
What this trial is testing

Fluvastatin After Heart Transplantation

Who this might be right for
Heart TransplantationHypercholesterolemia
University of Bologna 56
Not applicableUnknownNCT04351945
What this trial is testing

Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors

Who this might be right for
Endocrine System DiseasesThyroid DiseasesCortisol Deficiency+3 more
Semmelweis University Heart and Vascular Center 100
Early research (Phase 1)Study completedNCT01960322
What this trial is testing

Improving Medication-taking After Liver Transplant

Who this might be right for
NonadherenceTacrolimusPediatric Liver Transplant Recipients
Icahn School of Medicine at Mount Sinai 7
Not applicableStudy completedNCT04979754
What this trial is testing

REnal TRansplant Outcomes After CARdiac Surgery (RETROCAR)

Who this might be right for
Cardiac SurgeryCardiopulmonary BypassRenal Transplant Recipient
University Hospital, Bordeaux 93
Not applicableStudy completedNCT02852941
What this trial is testing

Assessment of Volumetric Hemodynamic Parameters and Nutritional Status in Stable Renal Transplant Recipients

Who this might be right for
Cardiac Output, LowHigh Blood Pressure
Medical University of Warsaw 80
Not applicableStudy completedNCT03574012
What this trial is testing

SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart

Who this might be right for
Acute Leukemia in RemissionHematopoietic Cell Transplantation RecipientLymphoma
Fred Hutchinson Cancer Center 41
Post-approval studies (Phase 4)UnknownNCT04193306
What this trial is testing

Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant Recipients

Who this might be right for
Cardiac Allograft Vasculopathy
Institute for Clinical and Experimental Medicine 126
Not applicableLooking for participantsNCT06774794
What this trial is testing

Precision Medicine in the Management of Heart Transplant Recipients

Who this might be right for
Heart Transplantation
IRCCS Azienda Ospedaliero-Universitaria di Bologna 200
Not applicableEnded earlyNCT00166153
What this trial is testing

Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept

Who this might be right for
Cardiac Transplantation
Emory University 30
Not applicableWithdrawnNCT01305395
What this trial is testing

Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients

Who this might be right for
Cardiac Allograft Vasculopathy
University of Minnesota
Not applicableActive Not RecruitingNCT05451979
What this trial is testing

HIIT in Pediatric Heart Transplant Recipients (MedBIKE™)

Who this might be right for
Pediatric ALLTransplant; Failure, Heart
University of Alberta 10
Large-scale testing (Phase 3)Looking for participantsNCT07079735
What this trial is testing

Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant

Who this might be right for
CMV ViremiaHeart Transplant InfectionHeart Transplant Failure and Rejection
Columbia University 150
Large-scale testing (Phase 3)Study completedNCT00150046
What this trial is testing

Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients

Who this might be right for
Heart Transplantation
Novartis Pharmaceuticals 176
Not applicableStudy completedNCT01796379
What this trial is testing

High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia

Who this might be right for
Heart Transplant RecipientsPhysical Fitness
Oslo University Hospital 80
Load More Results